Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply | Zendy

Hidekazu Suzuki | Zendy; Juntaro Matsuzaki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply

Author(s) -

Hidekazu Suzuki,

Juntaro Matsuzaki

Publication year - 2012

Publication title -

journal of neurogastroenterology and motility

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.345

H-Index - 42

eISSN - 2093-0887

pISSN - 2093-0879

DOI - 10.5056/jnm.2012.18.4.459

Subject(s) - medicine , irritable bowel syndrome , ideal (ethics) , lubiprostone , solifenacin , gastroenterology , psychotherapist , alternative medicine , constipation , pathology , overactive bladder , psychology , philosophy , chronic constipation , epistemology

The overall im-provement was assessed on the basis of the patients’ subjective re-ports during their interview regarding whether the symptoms had improved, compared to before administering solifenacin. Since the overall improvement is an established index often used in de-termining the therapeutic efficacy of irritable bowel syndrome (IBS), we do not think that the extremely high efficacy of sol-ifenacin in our paper

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research